Navigation Links
Simcere Pharmaceutical Group to Announce 2009 First Quarter Earnings on Monday, May 18, 2009
Date:5/5/2009

NANJING, China, May 6 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China, announced today that it intends to release its 2009 first quarter results on Monday, May 18, 2009, after the market closes in the United States. Simcere's chief executive officer, Jinsheng Ren, and chief financial officer, Frank Zhigang Zhao, will host an earnings conference call to discuss the company's 2009 first quarter results on Tuesday, March 19, at 8 a.m. ET (Tuesday, March 19, at 8 p.m. Beijing/Hong Kong time).

    To access the conference call, please dial:

     United States toll-free dial-in number:  +1.800.659.2056
     International dial-in number:            +1.617.614.2714
     North China toll-free dial-in number:    10.800.152.1490
     South China toll-free dial-in number:    10.800.130.0399
     Hong Kong dial-in number:                +852.3002.1672

Please ask to be connected to Simcere's Q1 2009 earnings call and provide the following passcode: 25770430. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the company's web site at http://www.simcere.com .

Following the earnings conference call, an archive of the call will be available by dialing:

United States toll-free dial-in number: +1.888.286.8010

     International dial-in number:            +1.617.801.6888

The passcode for replay participants is: 21293840. The telephone replay also will be archived on the "Investor Relations" section of the company's web site for seven days following the earnings announcement.

About S
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007
2. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
3. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
4. Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
5. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
6. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
7. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
8. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
9. Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase
10. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
11. Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2014)... Synedgen announced today the award ... Phase I contract from the National Cancer Institute ... to demonstrate proof-of-concept activity of Synedgen’s proprietary treatment ... tissue damage to the lining of the gastrointestinal ... award, Synedgen will complete efficacy studies for its ...
(Date:9/26/2014)... China Cord Blood Corporation (NYSE: CO ) ("CCBC" ... cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem ... 2014 annual general meeting of shareholders at its Hong ... Garden Road, Central, Hong Kong , at 9:00 ... Eastern Time on December 11, 2014). Shareholders of record ...
(Date:9/26/2014)... Molecular Biology deals with the ... regulation of cellular activity and its behaviour. It emphasise ... with its environment within the genome. Knowledge on molecular ... therapeutic methodologies for the diagnosis, prognosis and the treatment ... Dr. Srinubabu Gedela, MD of OMICS Publishing Group ...
(Date:9/26/2014)... “Inflamax’s Clinical Data Management group is a SCDM ... allows us to support our group in maintaining the ... Director of Data Management at Inflamax. “Being an ... Clinical Data Managers have been certified by passing the ... offering only the best services to our clients, by ...
Breaking Biology Technology:Synedgen Awarded National Cancer Institute Funding for Promising New Treatment for Medical Radiation-induced Bowel Injury 2China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 3
... N.Y., Nov. 5 BioSpecifics Technologies Corp. (Nasdaq: ... today announced its financial results for the third quarter ... happy that, in September of this year, the FDA,s ... 12-0, the approval of XIAFLEX(TM) for the treatment of ...
... November 5, 2009 Senomyx, Inc. (Nasdaq: SNMX ), ... discover novel flavor ingredients for the food, beverage, and ingredient ... results for the third quarter ended September 30, 2009. ... compared to $4.0 million for the third quarter of 2008, ...
... PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corporation (Nasdaq: ... the Company plans to release third quarter 2009 financial results ... The Company will hold a conference call ... quarter 2009 results. Listeners may access the call by,dialing ...
Cached Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
(Date:9/29/2014)... Juan Manuel Santos has presented Dr. Cristin Samper, ... with the prestigious Order of San Carlos. , ... foreign civilians and military officers who have made ... field of international relations. , An international authority ... was invited to the Colombian Residence in New ...
(Date:9/29/2014)... Va.September 29, 2014Research!America,s 19th annual Advocacy Awards ... who are trailblazers in advancing medical progress to ... nation. The event will take place on Wednesday, ... Auditorium in Washington, DC. , The 2015 Advocacy ... Robin Roberts; Michael Milken, founder of the Milken ...
(Date:9/29/2014)... 29, 2014 Growing Demand ... with Increasing Security Concerns Continue to Propel Biometrics ... is one of the fastest growing ... biometrics systems, majorly in various government projects such ... modality based biometrics dominates the country,s biometrics market, ...
Breaking Biology News(10 mins):Research!America to honor leaders in medical and health research advocacy 2Research!America to honor leaders in medical and health research advocacy 3Research!America to honor leaders in medical and health research advocacy 4India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 2India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 3
... Bar Harbor, Maine - Currently, 5-8% of the ... ( www.niaid.nih.gov ). Many of these are chronic ... aggregate within a single family, suggesting they are ... To help researchers investigate these common pathways, ...
... UT Southwestern Medical Center have eliminated non-small cell lung ... called BEZ235 in combination with low-dose radiation. In ... Cancer Research , UT Southwestern researchers found that if ... tumor cells with otherwise nontoxic radiation, the drug blocked ...
... are reporting results of one of the first studies ... anti-odor, anti-bacterial socks now on the market. Their findings, ... Environmental Science & Technology , may suggest ways ... these particles to the environment, where they could harm ...
Cached Biology News:UT Southwestern researchers use drug-radiation combo to eradicate lung cancer 2
... DNA120OP is specifically engineered for efficient drying ... incorporates a glass cover and a post-trap ... unattended, odor-free processing of samples in ammonium ... Synthetic Oligos , ...
... Maxi MB (for aqueous, other low volatility ... systems respond to specific applications of molecular ... concentration of heat-labile samples. The RC systems ... cold traps and a wide selection of ...
... The DNA120 is a dedicated concentrator for ... precipitates of DNA/RNA. The integrated system combines ... pump. The compact design, automatic pump and ... run time; one for heater time), makes ...
... 1 Block MBS Start up kit. Includes ... and choice of 1 MultiBlock satellite ... 30 blocks. User friendly software. ... Adjustable height heated lid. Outstanding uniformity. ...
Biology Products: